 treatment symptomatic human immunodeficiency virus type infection native interferon-alpha zidovudine Patients advanced human immunodeficiency virus type infection treatment zidovudine AZT months IU native interferon-alpha IFN-alpha months Infectious HIV plasma patients cases high titers IFN-alpha treatment correlation HIV titers antigen levels Antiviral activity levels infectious virus antigen treated patients termination IFN-alpha treatment significant rise antigen levels IFN treatment absolute cell counts tendency increased rate decline side effects severe anti-HIV effect vivo IFN-alpha dosages viable additional treatment immunodeficient patients AZT therapy